ArticleFrontiers in pharmacology2020

Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors.

Laura Schäkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.